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Amphotericin B and Amphotericin B methylester: Effect on brush
border membrane permeability. In order to explain the nephrotoxicity
of polyene antibiotics such as Amphotericin B (AM), an effect on the
tubule membrane permeability has been postulated. However, studies
on the action of AM have been complicated by the use of sodium
deoxycholate (DOC), a membrane dissociating detergent as a solvent.
Recently, a derivative, the methylester aspartate salt of Amphotericin B
(AME) has been synthesized, which is highly water soluble in the
absence of organic solvents. We have tested the action of AM, DOC,
and AME on the sodium permeability of brush border (BBM) vesicles
isolated from rat kidney cortex. It was found that both AM and AME
increased the 22Na uptake as measured by a rapid filtration technique.
However, a large fraction of the AM action was due to the effect of
DOC on the BBM sodium permeability. We also investigated the time—
and dose—dependent action of AME on 22Na and 3H-D-mannitol efflux
from BBM vesicles. After 15 sec of exposure, efflux from 22Na-
preloaded vesicles was unchanged in the presence of 1 p.g AME/mg
protein compared to control vesicles. With 10, 50, and 100 zg AME/mg
protein, the efflux increased 16, 25, and 35% respectively; 260 jzg
AME/mg protein did not elicit a further increment in the 22Na efflux. In
the same membrane vesieles 3H-D-mannitol etilux did not change. After
preincubation of the membranes for 60 mm with different concentra-
tions of AME, the 15 sec 22Na efflux increased 26% in the presence of
I zg/mg protein AME with no change in the 3H-D-mannitol efflux. At
higher concentrations of AME (200 and 300 g/mg protein), an increase
in 22Na efflux (36%), but also an increased 3H-D-mannitol efflux (26 and
63% respectively) was observed. These studies demonstrate that AME
increases the Na permeability of BBM in a time— and dose-dependent
manner. At higher concentrations and with longer incubation periods,
AME additionally affects the overall membrane permeability. The
increase in sodium permeability and the breakdown in membrane
barrier may be among the factors responsible for the nephrotoxicity of
Amphotericin B and its derivatives.
Amphotericin B (AM) is the most effective agent currently
available for the treatment of many systemic fungal infections in
man. The drug is used in the treatment of a number of mycoses
that, prior to its availability, were invariably fatal. The use of
AM, however, is restricted to a significant degree by a variety
of toxic effects, the most serious of these being nephrotoxicity
[1—3]. Over 80 percent of patients treated with AM develop
impairment of renal function [41, and it is often the degree of
kidney malfunction and not the therapeutic response of the
mycosis that determines the duration of treatment.
Two mechanisms have been implied in nephrotoxicity by
AM: 1) a hemodynamic effect [5—71, and 2) an increased tubular
permeability (6—10) mainly in the distal tubule, but also in the
proximal tubule. This action can be related to increase in the
solute permeability of plasma membranes produced by interac-
tion of the antibiotic with membrane bound sterols [11]. Early
experiments which showed that AM, as other polyene antibiot-
ics, was without effect in cell—free systems indicated that the
cell membrane was the target of antibiotic activity. Moreover,
the observation that bacteria and bluegreen algae, which have
no membrane sterol, were resistant to the polyene antibiotic
implied that membrane sterol was absolutely required for
polyene activity [121. The studies of the action of AM on
membrane permeability in the kidney have been complicated,
however, by the simultaneous presence of sodium deoxycho-
late (DOC) used as a solvent for AM. This compound has been
demonstrated to have an effect on the sodium permeability of
brush border membranes isolated from hamster jejunum, for
example [131, and at higher concentrations is an effective
detergent for brush border membranes [14]. The recent synthe-
sis of the water soluble derivative of AM, the methylester
aspartate salt of Amphotericin B (AME), which has also
antifungal activity, avoids these difficulties.
The technique of isolating brush border membranes (BBM)
from proximal tubules [15] provides a tool to test directly the
effect of AM anti AME on the luminal membrane of the
proximal tubule. In rabbit brush border membranes, AM (in the
presence of DOC) was shown to increase sodium permeability,
thereby inhibiting sodium dependent D-glucose uptake [161.
We had three objectives in this investigation. First we wanted
to determine whether DOC, AM, and AME increase the sodium
permeability of the BBM in the rat kidney. Second, we studied
the dose and time dependence of the action of AME on the
sodium permeability. Third, we were interested whether AME
also effects the brush border membrane permeability for man-
nitol, which in in vivo studies had been used as indicator for
membrane integrity 171.
Our results demonstrate that AM and AME at low doses and
after short application increase the permeability of the brush
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border membranes to sodium, whereas longer exposure with
higher concentrations of AME leads, in addition, to an increase
in mannitoi permeability. Both factors, the increased ion per-
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meability and the general breakdown of the membrane barrier,
can contribute to the reported nephrotoxicity of these two
polyene antibiotics.
Methods
Isolation of brush border membrane (BBM) vesicles
Male Wistar rats, 180 to 220 g body weight, were killed by
cervical dislocation, and their kidneys were placed as rapidly as
possible into ice—cold mannitol buffer (10 msi mannitol, 2 mM
Tris-HCI adjusted to pH 7.1). They were decapsulated and thin
slices of the renal cortex were prepared. The tissue was
weighed and placed in mannitol buffer to give a 10% suspen-
sion. The membrane preparation was carried out according to
the divalent ion precipitation method described by Evers et a!
[151. The procedure consists of a series of centrifugation steps
by which BBM were separated from nuclei, mitochondria, and
endoplasmic reticulum. Al! the centrifugation steps were per-
formed at 4°C in a Sorvall RC-5B centrifuge using a SS-34 rotor.
The purity of the final vesicle fractions was monitored by
assaying the activity of marker enzymes—alkaline phosphatase,
located in the brush border mierovilli, Na-K-ATPase in basal—
lateral membranes, and succinic dehydrogenase in the mito-
chondria. The ratio between the specific activity in the mem-
brane fraction and in the corresponding kidney cortex
homogenate was the enrichment factor. It amounted in these
experiments to 13.0 1.2 (mean SD) for alkaline phospha-
tase, to 0.60 0.21 for Na-K-ATPase, and to 0.02 0.006 for
succinic dehydrogenase.
Protein and enzyme assay
Protein was determined after membrane precipitation with
ice—cold trichloroacetic acid (10%) by a modified Lowry proce-
dure with bovine serum albumin as a standard [17]. Alkaline
phosphatase (E.C. 3.1.3.1) and Na-K stimulated ATPase (E.C.
3.6.1.3) were determined as described by Berner and Kinne
[18]. Succinic dehydrogenase (E.C. 1.3.99.1) was determined
by the method of Gibbs and Reimer [19].
Transport measurements
Uptake studies. The final membrane pellets were suspended
in vesicle buffer, 100 ms'i mannitol, 20 msi Tris-HEPES (Tris is
Tris(hydroxymethyl)aminomethane, HEPES is 4(2-hydroxy-
methyl)-piperazine-N'-l-ethanesulfonic acid), pH 7.4, by gentle
suction through a 26- 1/2 gauge needle. The uptake of 22Na was
followed by a rapid filtration technique [15]. Twenty 1d of
membrane suspension kept at 0°C were added at 0 time to 120
1d of incubation medium filtered through a 0.45 Millipore filter
prior to use. Uptake was stopped by withdrawing 20 l of the
incubation mixture and adding them to 1 ml of ice—cold stop
solution. The resultant suspension was rapidly filtered through
a mixed cellulose ester filter (Millipore, HAWP pore size 0.45) kept under suction. The filter was then washed with 3.5 ml
ice—cold stop solution (100 mrvi mannitol, 20 mM Tris-HEPES,
150 mM MgC12) adjusted to pH 7.4 with Tris base. The washing
took less than 2 see; the total time between dilution of the
sample and completion of filtration was 15 sec. Experiments
were performed in duplicate at 25°C.
The various media contained 100 m'vi mannitol, 41 ms NaCl,
20 msi Tris-HEPES, pH 7,4, and, in addition, either Ampho-
tericin B (23 pg/mg protein) and sodium deoxycholate (20
pg/mg protein), or deoxycholate alone (20 j.Lg/mg protein), or
Amphotericin B methylester (90 pg/mg protein). Sodium deoxy-
cholate was tested because Amphotericin B as provided by
Squibb (FungizoneR) contains sodium deoxycholate as solvent.
The filters were transferred into liquid scintillation fluid
(Econofluor, New England Nuclear, Boston, Massachusetts,
USA) and counted by standard liquid scintillation techniques.
Filter blanks were determined by adding 20 1.d of vesicle buffer
instead of membranes to each incubation medium. The blank
values were substracted when calculating the amount of isotope
taken up by the membranes.
Efflux studies
Efflux studies were carried out by preincubating brush border
membranes for 60 minutes at 25°C in a medium containing 100
mM mannitol, 100 mrvi NaCl, 10 mtvt KCI, 20 mi Tris-HEPES
pH 7.4, 10 tCi 22NaC1, 25 Ci 3H-D-mannitol, pIus 0.3 .tg
valinomycin dissolved in 0.06% ethanol in order to equilibrate
the vesicles and to abolish any transmembranal electrical po-
tential difference. At time 0, a 20 d sample of the preincubated
membranes was added to 120 1.d efflux medium containing 100
m choline chloride (choline as substitute for Nat), 10 mM
KC1, 100 mM mannitol, and 20 mrvi Tris-HEPES adjusted to pH
7.4. Furthermore, various amounts of Amphotericin B methyl-
ester were present as detailed in the legends of the figures.
Two types of transport were performed: 1) the 22Na and the
3H-D-mannitol efflux from vesicles was determined into a
medium containing also 1, 10, 50, 100, and 200 g AME/mg
protein, and 2) the 22Na and the 3H-D-mannitol efflux was
measured from preloaded vesicles that had been exposed for
one hour at 25°C to 1, 200, and 330 AME/1g protein. The
efflux medium contained the corresponding concentration of
AME.
Sampling was carried out as described for the uptake studies
and the amount of sodium remaining in the vesicles was
determined by the rapid filtration technique detailed above.
In order to determine the amount of sodium and mannitol
present in the vesicles at the beginning of the efflux, 5 1d of the
vesicle suspension were added directly to 1 ml ice—cold stop
solution (100 mrvi mannitol, 20mM Tris-HEPES, 150 mi's MgCl2,
pH 7.4) and the samples processed as described above. The
corresponding values are reported in the legends to the figures.
Chemicals
22NaCl (carrier free) and 3H-D-mannitol (15 to 30 Ci/mmol)
were purchased from New England Nuclear, Boston, Massa-
chusetts, USA. Valinomycin was obtained from Sigma, St.
Louis, Missouri, USA. Amphotericin B (FungizoneR) was
purchased from E.R. Squibb. All other chemicals were of the
highest grade of purity commercially available.
Results
Effect of deoxycholate, Amphotericin B, and Amphotericin B
methylester on Na± uptake
As shown in Figure 1, presence in the uptake medium of DOC
alone, AM and DOC (FungizoneR), and AME increased the rate
of Na uptake.
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The increase of sodium uptake by AM was also observed
when experiments were carried out at a higher buffer capacity
50 mM Tris-HEPES inside and outside the vesicles) and in the
presence of 1 msi amiloride. A direct or indirect involvement of
the Na/H exchanger in the increased sodium uptake can,
therefore, be excluded, In addition, the AM-induced sodium
aptake was found to be dependent on the nature of the
tccompanying anion. It was highest in the presence of the
iighly permeant nitrate and lowest in the presence of glyconate
(AM-dependent sodium uptake in 41 m nitrate = 18.6
pmoles/mg protein x 5 s, in 41 msi gluconate = 9.5 pmoles/mg
protein x 5 s, in 41 mM chloride 11,3 pmoles/mg protein X 5s,
mean values from six determinations). This result indicates that
AM opens a conductive pathway for sodium in the brush border
membrane.
The finding that AM modifies the sodium permeability of
BBM of rat kidney is similar to the effect found in sheep red
cells [201, rabbit kidney [16], necturus proximal tubule [16],
toad [21] and turtle bladder 122]. It should be pointed out,
however, that about 40 to 50% of the action of Fungizone is due
to the presence of DOC used as solvent for AM. The concen-
tration of DOC tested in our experiments is the same as present
in the Amphotericin B solution prepared from Fungizone. As
also shown in Figure 1, the effect of 23 g AM/protein is about
equal to the effect of 90 xg AME/mg protein. This discrepancy
in concentrations is probably due to a different partition of the
two compounds between aqueous and membrane phase, as
pointed out by Dennis and coworkers [23].
Effect ofmethylester Amphotericin B on the sodium and
mannitol efflux
Dose dependence. Figure 2 shows the effects of various doses
of AME on the Na efilux from BBM vesicles preloaded with 100
mM NaCI and placed in a medium where sodium was substi-
tuted by choline. It can be seen that AME at 1 .rg/mg protein
does not exert any statistically significant action on the Na
efflux, while at 10 rg/mg protein it significantly (P < 0.05)
increased the Na efflux that reached the maximum with a
dosage of above 100 xg AME/mg protein. Figure 3 depicts the
concentration dependence. In this figure, the log of the 15 sec
sodium efflux is plotted against the log of the AME concentra-
tion (pg/mg protein) since it has been observed [II] that in other
systems the permeability changes p can be described by the
equation logp = loga + n log CA, where CA is the concen-
tration of the antibiotic; a and n are constants. A linear
correlation is obtained with a regression line y = 0.48 0.37x
(r2 = 0.99). The value of n is 0.4.
Another point that deserves comment is the very short time
needed by AME to exert its action. Our earliest time points
were taken at 15 see, and this was already long enough to show
the AME effects. In other tissues where the action of AM was
tested, the effect occurred also almost instantaneously [16—21].
Figure 4 shows the mannitol efflux from the same BBM vesi-
cs. Mannitol was chosen as an indicator of membrane integ-
rity [18]. It is possible to see that for the selected short time of
incubation, no effect on mannitol efflux was induced even at
concentrations as high as 200 xg AME/mg protein. It should be
noted that the efflux of mannitol at lower AME concentration
was also not different from control values,
Fig. 1. Sodium uptake by brush border membrane vesicles isolated
from rat kidney cortex. Vesiclescontaining 100 m mannitol and 20 mM
Tris-HEPES pH 7.4 were incubated in a medium containing in addition
61 mvi NaCI, 10 /LC 22Na. Na uptake (nmol/mg protein) at equilibrium
for each experimental group is the following (mean SE): Control 50.9
8.9; DOC 50.3 10.1; AME 56.8 11.2; AM 58.7 12.7. No
significant difference was found between each experimental group.
Symbols are: (•—-•) uptake into vesicles in absence of any drug;(•—•) uptake into vesicles in the presence of DOC (20 pg/mg protein);
(A—A) uptake into vesicles in the presence of AME (90 /Lg/mg protein);
(—1) uptake into vesicles in the presence of FungizoneR AM (23
jzg/mg protein) and DOC (20 pg/mg protein). Data are given in % of
equilibrium value observed of each experimental setup and represent
mean values so from five paired experiments using 10 rats per
experiment. Statistically significant differences of P < 0.02 were found
for each time point between control and DOC, control and AME, and
DOC and AM using Student's t-tcst for paired data.
Time dependence. Since the interaction between AME and
membranes involves partition of the compound between the
incubation medium and the membranes, a time dependency
would be expected. Figure 5 shows the results when sodium
preloaded BBM vesicles were preincuhated for 60 mm in media
containing different amounts of AME, and thereafter transport
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Fig. 2. Sodium efflux studies at 25°C from brush border membrane
vesicles in the presence of different amounts ofAME. The vesicles were
preincubated for 60 mm in a medium containing 100 mr'.i mannitol, 100
mM NaCI, 10 m KC1, 20 msi Tris-HEPES, pH 7.4, 10 sC 22NaC1, and
0.3 pg of valinomycin. At time 0 the 20 jsl of the preinciibated vesicles
were put in a medium where Na was substituted by choline; further-
more, this medium contained varying amounts of AME. In order to
determine the sodium present in the vesicles at the end of the prein-
cubation period, 5 jsl of the vesicle suspension were added to I ml
ice—cold stop solution (100 mi mannitol, 20 m Tris-HEPES, 150 mM
MgCI2, pH 7.4) and the samples processed as described above. It
amounted to 56.2 4.6 nmol/mg protein. Data represent mean value
5EM from five paired experiments, using 10 rats per experiment and they
are expressed as % of the 0 time value. A statistically significant
difference of at least P < 0.02 was found for each time point between
control and the AME-conlaining samples. Symbols are: I Control; A I
pg/mg protein; 1 10 pg/mg protein: 50 pg/mg protein; 7 100 pg/mg
protein; 200 pg/mg protein.
studies were performed. It is evident that under these condi-
tions, already a concentration of 1 sg AME/mg protein had a
significant effect (P <0.05) on the Na ernux, which amounted to
81% of the maximum. It should be underlined that this dose did
not change the membrane permeability to Na in vesicles not
preincubated with AME.
In Figure 6 the corresponding values of mannitol efflux are
presented. At I Lg/mg protein no change is observed. At a
I I I I
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Fig. 3. Sodium efflux from brush border membrane vesicles plotted
against ihe Concentration of AME. Each point represents the log of the
15 sec sodium efflux for the corresponding log of the AME con-
centrations.
concentration of 200 pg/mg protein, however, a 26% increase
(P < 0.02) in the mannitol efflux was registered. At 330 pg/mg
protein, an even higher efflux (63% increase, P < 0.01) was
detected.
Thus, preincubation of the membranes with 1 Lg/mg protein
Amphotericin B methylester potentiates its effect on sodium
permeability, whereas preincubation with high concentrations
additionally affects the mannitol permeability.
Discussion
The present experiments clearly demonstrate that AM and
AME increase the permeability of BB membranes of rat prox-
imal tubules. These findings confirm recent results of Cheng et
al 17], obtained in in vivo condition, and are in agreement with
other reports on the changes of the permeability properties
induced in other cell systems by the quoted polyene antibiotics.
Indeed, Deuticke, Kim and Zoeliner showed that Amphoter-
icin B increases the leakage of K, glycerol, SCN, and Cl
from porcine RBC's [11]. Anhert—Hilger et al showed that Am-
photericin B increases the permeability of rat and human RBC
membranes to K and Na [24]. Furthermore, Andreoli,
Dennis and Weigl demonstrated that Amphotericin B modifies
the permeability propel-ties of thin lipid membranes formed
from solutions containing sheep red cell phospholipids and
cholesterol [20]. Finally, there is also evidence that Amphoter-
icin B induces permeability changes in the luminal membranes
of Necturus proximal tubule [16], in the mucosal side of turtle
and toad bladder [21—22], and in BBM isolated from rabbit
kidneys [161.
In the uptake studies, we have shown that the effect of AM is,
in part, mediated by the use of sodium deoxycholate (DOC),
present in the pharmaceutical form of the drug as a solvent. It
was shown that DOC increased the rate of Na uptake and
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Fig. 4. Mannitol efflux at 25CC jro,n BBM i'esicles in the absence(•—•) and in the presence (U—U) of AME (200 p.glmg protein). The
experiments were performed as described in the legend of Figure 2, in
the presence of 25 jaC 3H-D-mannitol. The mannitol present in the
vesicles at time 0 amounted to 285 26.4 nmol/mg protein (mean SD).
No effect was found when the vesicles were tested in the presence of
the lower concentration of AME. Data are given in % of equilibrium
value derived in each experimental setup and represent mean values
so from five paired experiments using 10 rats per experiment.
inhibits the Na-coupled accumulation of D-glucosc and L-
alaninc in BBM vesicles from hamster jejunum [13]. However,
when DOC was tested on the mucosal surñsce of the toad
bladder [21], it failed to stimulate Na transport measured as
short circuit current. This discrepancy could he explained on
the basis of the permeability differences between the two types
of epithelia or differences in the structure and composition of
the plasma membranes.
The effect of Amphotericin B methylester on the sodium
uptake confirms that this compound exerts the same type of
action as the AM parent compound. Indeed, it has been shown
that AME produced comparable permeability changes as AM
on artificial membranes 123]. This fact plus the hydrophilicity of
AME that avoids the use of DOC, made AME more suitable for
the time- and dose—dependent studies.
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Fig. 5. Sodium efflux at 25°C from BBM m'esicles preincubated for 60
minutes in the presence of various amounts of AME. After a one hour
equilibration period, identical to what is detailed in the legend of Figure
2, the vesicles were further incubated for 60 mm in thc same medium as
before in the absence (0—I) and in the presence of AME, I hag/mg
protein (A—A), 200 pg/mg protein (U—U). 330 pg/mg protein (•—•).
The sodium present in the vesicles at the end of 120 mm was determined
by adding 5 piofvesicles suspension to 1 pA ice—cold stop solution (100
mM mannitol, 20 mvi Tris-HEPES, ISO mM MgCl2, pH 7.4) and the
samples processed as described above. It amounted to 53.1 5.3
nmol/mg protein. Data represent mean values SEM from five paired
experiments using 10 rats per experiment and they are expressed as
of the 0 time value. A statistically significant difference of at least P
0.02 was found at each time point for control versus all AME containing
samples and between the samples containing I jsg/mg protein AME and
200 Lg/mg protein AME.
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The understanding of the mechanism(s) of action of the
polyenes is mainly based on studies of artificial lipid membranes
[20, 23, 25]. These studies provided evidence that the interac-
tion of polyene antibiotics with membrane cholesterol induces a
rearrangement of membrane lipids that produces aqueous chan-
nels. Therefore, the presence of cholesterol molecules, acting
as receptors of the antibiotics, is essential in the induction of the
AM and AME effects.
From previous studies, we know that the cholesterol content
of isolated BB membranes of rat kidney is around 200
nmoles/mg [141; therefore, we should expect that the maximum
316 Capasso ci a!
100
><
' 50 —
0
0(0
I •IA
I •1•
0—I I I I
0 1 2 3
Incubation time, mm
Fig. 6. Mannitol efflux at 25°C from BBM vesicles in the absence
(I—S) and in the presence of AME, 1 pg/mg protein (A—A), 200
pg/mg protein (N—U), 330 pg/mg protein (•—•). These experiments
were performed as described in Figure 5. After one hour equilibration
period identical to what is detailed in the legend of Figure 2, but in the
presence of 25 Ci H3-D-mannitol, the vesicles were further incubated
for 60 mm in the same medium with and without AME. Data represent
mean values SEM from five paired experiments using 10 rats for
experiment and they are expressed as % of the initial tissue value. A
statistically significant difference of 0.01 <P < 0.02 was found at each
time point between control and samples containing 200 pg or 330 Lg/
AME as well as between the samples containing 200 pg/mg protein
AME and 330 pg/mg protein AME, respectively.
effect of ÂME on the Na permeability should be obtained with
a concentration of 200 nmoles/mg, assuming a 1:1 interaction.
This value is in the range that we have experimentally found in
the short term experiments.
With respect to mannitol, we have shown that after one hour
of preincubation, using a high dosage of AME, there is an
increase in mannitol permeability that was not present after
short exposure of the membranes to AME. It thus seems that
AME, in addition to forming specific channels, also affects the
membrane integrity, at least after one hour of incubation and at
a relatively high dosage. At low doses of AME (1 pg/mg
protein) this disturbance of the membrane integrity should not
occur because predominantly cholesterol AME complexes are
present. The same holds for the short exposure because the
membranes are not yet equilibrated with AME and the concen-
tration in the membrane is much lower than after preincubation,
Measurements of permeabilities, hydraulic, and reflection
coefficients in artificial lipid membranes treated with AM (and
AME) suggest radii of the specific channels of around 4 3 to
4 . 6 A [26]. Considering an equivalent radius of mannitol, we
would not expect a significant increase in the mannitol effiux in
the first set of experiments. On the other hand, since morpho-
logical and physiochemical data show that the formation of
complexes between polyene antibiotics and membrane choles-
terol molecules goes along with a reorientation of membrane
lipids [27], it is entirely possible that, beyond the saturation
concentration of AME and/or with long exposition to the drug,
unspecific alterations of the membrane permeability can occur.
This alteration could create pores large enough that molecules
like mannitol can penetrate. The finding of an increase in the
mannitol and inulin permeability in proximal tubules of rats
exposed in vivo for three hours to AM further strengthens this
proposed model of action [7].
It should be pointed out that also some differences between
AM and AME in the dose—dependent action are evident.
Analysis of the data reported in Figure 1 reveals that after
correction of the AM effect for the permeability change induced
by DOC, four to five times more AME than AM is required to
exert the same increase in permeability. The lower activity of
AME has also been observed in lipid bilayers where a tenfold
concentration difference was found [23]. The reason for this
difference is not completely clear, although it may depend on
the equilibrium distribution of these agents between aqueous
and membrane phases. Therefore, we should expect that ÂME
would exert its action on the permeability properties of BBM at
higher concentration than AM.
How can these findings obtained in vitro be used to explain
the changes in kidney function in vivo? As already mentioned,
the first change observed after AM application is a reduction in
GFR followed by an increase in proximal tubule mannitol and
inulin permeability [7]. An impairment of distal tubular function
has also been found [8, 9], although the time course for this
process has not been determined.
Although it is difficult to compare in vivo versus in vitro
results, because of uncertainties about species differences and
the lack of knowledge about the actual concentration at the site
of action, it is noteworthy that in man doses of AM, up to 1
mg/kg are used in the treatment of mycotic infections. This
amount would give a blood concentration of about 14
!Lmolcs/liter, which falls into the range of concentrations used
in this study.
According to our data, this concentration would lead to an
immediate change of the ion permeability of the brush border
membrane. The same phenomenon might occur at the distal
tubule and might be the cause for the impaired urinary acidifi-
cation and the hyperkalemia [8]. Also in the thick ascending
limb, Amphotericin B increases the ion permeability of the
membranes, as indicated by a strong stimulation of 02 con-
sumption in isolated cells (Silva and Kinne, unpublished data).
This action might be related to the hyposthenuria and polyuria
found after Amphotericin infusion [8]. Following the same line
of reasoning, one can envisage that also macula densa cells arc
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affected. An increase in the entry of Na into these cells will lead
to a depolarization of the cell membrane with a consequent rise
in the C1 cell concentration, This phenomenon might induce a
decrease in the glomerular filtration rate (GFR) through the
tubule glomerular feedback mechanism [28]. AM could equally
well impair renal hemodynamics via physical factors or humoral
factors initiated at the level of the proximal tubule. Further-
more, we can also speculate that AM could induce a decrease in
GFR by increasing the entry of Na in the podocytes cells. The
increased concentration of NaCl, producing a cell swelling, will
cause an occlusion of the filtering pores of the glomerula
epithelia.
In conclusion, the studies reported above demonstrate that
Amphotericin B and its methylester derivative increase the
sodium permeability of BBM. Moreover, the action of AME is
time and dose dependent. At high concentration and with a long
incubation period, AME additionally effects the overall mem-
brane permeability as shown by the increased mannitol efflux.
Therefore, we add new evidence to the hypothesis [6, 7] that the
nephrotoxic effect of AM might be induced by one basic
mechanism, that is the increase in membrane permeability.
First, there is a hemodynamic effect mediated by the
tubular—glomerular feedback mechanisms that is activated by
the increased entry of NaC1 into the macula densa cells.
Thereafter, with increasing AM concentration in the membrane
there is a breakdown of the membrane barrier for larger
molecules, affecting the tubule function. The latter action could
well explain the chronic nephrotoxic effect of AM.
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